Streetbeat News

Revenues

AAWH

AYRWF

CRLBF

CURLF

GTBIF

TCNNF

TRSSF

VRNOF

U.S. multi-state operators (MSOs) in the cannabis industry are showing improved cost efficiency in Q2 2024, with six out of the top eight MSOs reducing their cost of goods sold (COGS) as a percentage of revenue. Companies like Green Thumb Industries, Curaleaf, Trulieve, Verano, Cresco Labs, and Ascend Wellness have managed to lower their COGS and selling, general, and administrative (SG&A) expenses, indicating better operational efficiency. However, AYR and TerrAscend faced increased COGS, highlighting operational challenges.

Portfolio Pulse from Rolando García

August 12, 2024 | 11:35 pm

ODV

Osisko Development (NYSE:ODV) reported a significant decline in its Q2 financial performance, with EPS dropping to $(0.25) from $(0.12) YoY and sales plummeting to $1.92M from $8.07M YoY.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 10:02 pm

JHX

James Hardie Industries has reaffirmed its FY25 guidance despite anticipating a challenging market backdrop in North America during its fiscal second quarter. The company expects North American volumes to be between 705 million to 735 million standard feet and EBIT margins to range from 27.5% to 29.5% for Q2 FY25. Full-year guidance remains unchanged with North American volumes projected at 2.95 to 3.15 billion standard feet, EBIT margins at 29% to 31%, and adjusted net income between $630 million to $700 million.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 10:00 pm

JHX

James Hardie Industries reported its Q1 FY25 results with an adjusted EPS of $0.41, up 4% year-over-year, and net sales of $992 million, also up 4% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 9:57 pm

MEOH

Methanex has temporarily idled its manufacturing operations in New Zealand until the end of October 2024. The company has entered into short-term commercial arrangements to supply its contracted natural gas to the New Zealand electricity market, which is expected to positively impact its Q3 and Q4 2024 earnings.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 9:37 pm

FLYX

flyExclusive reported a Q1 EPS of -$0.35 and a revenue increase of 3.8% to $79.97 million.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 9:30 pm

ORCL

Oracle (NYSE:ORCL) has outperformed the market over the past 5 years with an average annual return of 19.86%, resulting in a $100 investment growing to $252.10. The company's current market capitalization is $365.37 billion.

Portfolio Pulse from Benzinga Insights

August 12, 2024 | 9:30 pm

ACM

AECOM (NYSE:ACM) has significantly outperformed the market over the past 5 years, delivering an average annual return of 23.58%. A $1000 investment in ACM 5 years ago would now be worth $2,926.94. The article highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

August 12, 2024 | 9:30 pm

DYN

Dyne Therapeutics expects to have $778.8 million in cash and equivalents by the end of June, which is projected to fund its operations at least into the second half of 2026.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 9:22 pm

ATRA

Atara Biotherapeutics announced that it expects its cash runway to extend into 2027, which will support key pipeline readouts. The company plans to initiate a trial for ATA3219 in Systemic Lupus Erythematosus in the fourth quarter, with initial data expected by mid-2025.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 9:17 pm